Mesoporous Silica Particles as a Multifunctional Delivery System for Pain Relief in Experimental Neuropathy

详细信息    查看全文

• 作者：Junran Xie ; Dongju Xiao ; Jinning Zhao ; Nianqiang Hu ; Qi Bao ; Li Jiang and Lina Yu
• 刊名：Advanced Healthcare Materials
• 出版年：2016
• 出版时间：May 25, 2016
• 年：2016
• 卷：5
• 期：10
• 页码：1213-1221
• 全文大小：3216K
• ISSN：2192-2659

文摘

The long-term use of potent analgesics is often needed to treat chronic pain. However, it has been greatly hindered by their side effects such as addiction and withdrawal reactions. The study seeks to circumvent these drawbacks by taking advantage of a multifunctional delivery system based on nanoparticles to target on pathological neuroinflammation. A drug delivery system is designed and generated using mesoporous silica nanoparticles (MSNs) that are loaded with Δ9-THC (Δ9-tetrahydrocannabinol, a cannabinoid) and ARA290 (an erythropoietin-derived polypeptide), both of which possess analgesic and anti-inflammatory functions. The actions of such THC-MSN-ARA290 nanocomplexes depend on the enhanced permeability and retention of THC through nanosized carriers, and a redox-sensitive release of conjugated ARA290 peptide into the local inflammatory milieu. The biosafety and anti-inflammatory effects of the nanocomplexes are first evaluated in primary microglia in vitro, and further in a mouse model of chronic constriction injury. It is found that the nanocomplexes attenuate in vitro and in vivo inflammation, and achieve a sustained relief of neuropathic pain in injured animals induced by both thermal hyperalgesia and mechanical allodynia. Thus, a nanoparticle-based carrier system can be useful for the amelioration of chronic neuropathic pain through combinatorial drug delivery.